From eNewsletter 9/21/2022
DID YOU KNOW that a new study from American Journal of Geriatric Psychiatry found that both yoga and cognitive-behavioral therapy (CBT) provided meaningful improvements in worry, anxiety, and insomnia in adults over 60 that lasted even 6 months after discontinuing treatment? The majority of participants reported meaningful clinical improvements in generalized anxiety symptoms, depressive symptoms, and fatigue. The great thing about CBT and yoga is that they can be done in a group setting, one-on-one, or with the proper training, performed via online instruction.
Bonnie Minsky Award Winner The 2022-2023 recipient of the UIC School of Public Health Bonnie C. Minsky Award Fund is Laura Howenstine. Laura is a second year PhD candidate in the division of community health sciences whose research interest is in school-based health interventions. While her journey as a doctoral student is in its early stage, Laura hopes to use her degree for Youth-led Participatory Action Research to address health equity issues in schools. She is extremely grateful to have been selected for the Bonnie C. Minsky Award. “This scholarship will help me continue to grow as a public health student and allows me to further my passion of making meaningful change in the lives of children.”
Steve Minsky MS, HWC The clinician of the future is here now. Steve just completed his Masters of Science (MS) with honors in Health and Wellness. As a Health and Wellness Counselor, he will continue to analyze and offer solutions to optimize not only the food you eat, but every aspect of your lifestyle, whether for prevention or healing. More information on Steve's services.
Text Us We accept text messages. Type (847) 498-3422 and text away!
Virus Prevention and Support SARS-CoV-2, the virus that causes COVID-19, is here to stay. Moreover, we are exposed to many other viruses including influenza (flu), norovirus (stomach flu), adenovirus (common cold), monkeypox, and four other coronaviruses (common cold), among others. We recommend supporting your immune system year-round. For more information, refer to our Prevent and Fight Viruses 2.0 Protocol here.
Post-Acute Sequelae of SARS-CoV-2 Infection or "Long COVID" Action Plan 3.0 Post-Acute Sequelae of SARS-CoV-2 infection (PASC) or "Long COVID" includes symptoms that can last for 12 weeks or more. If you, a family member, friend, coworker, or neighbor are suffering from PASC, follow our Post-Acute Sequelae of SARS-CoV-2 Infection Action Plan 3.0. It is available for purchase here (password: discount2018).
COVID-19 Vaccine Information *Fall Booster Update Our opinion can be found at this link and is continually updated.
Have a happy, healthy day! Steve and Bonnie Minsky
In Today's Issue...
Well Connect - Vagus Nerve Stim*
Looking Beyond Cholesterol
September 20% OFF Sale Items
Chiro Corner NEW!
Blog Briefs NEW!
Well Connect Member Benefits
*Paid Member Access Only
Looking Beyond Cholesterol
Steve and Bonnie: In the upcoming October issue of Current Opinion in Endocrinology & Diabetes and Obesity, the authors suggest that low-density lipoprotein (LDL)-cholesterol level is a weak predictor of developing cardiovascular (CV) disease and can only explain a small proportion of CV risk. This should not be the first time you've heard this in our newsletter. LDL is not even used to determine CV risk on either the atherosclerotic cardiovascular disease (ASCVD) calculator in the United States, or the Qrisk3 in the UK. A study in JAMA in 2022 suggested that "the absolute benefits of statins are modest and may not be strongly mediated through the degree of LDL reduction". The authors purport that perhaps it is time to look beyond cholesterol to a different causal model, the ‘thrombogenic’ model of ASCVD. By thrombogenic, they are referring to damaged vessels that carry blood, such as arteries. There are numerous other conditions leading to this kind of damage, such as COIVD-19, which can trigger thrombus formation, causing strokes and myocardial infarctions. Although these are acute events, they highlight a mechanism for the development of ASCVD which centers on vessel damage and thrombus formation as both the primary causal mechanism for acute events, and the driver behind progression towards atherosclerotic plaque development. As we have said, you must consider many different blood test markers, including but not limited to, C-reactive protein, Homocysteine, Lp(a), triglycerides, LDL particle size, blood sugar markers, HDL, among others. Assessing CV risk is multifactorial, and the cholesterol hypothesis that suggests a raised LDL is directly causal for ASCVD is myopic, and does not adequately explain risk in individuals, or populations for that matter.